Abstract
The occurrence of abnormal levels of AI(III) connected with human pathologies and with encephalopathies experimentally induced in experimental animals is reviewed and critically evaluated in molecular terms. It is assumed that phosphate-bearing biomolecules are elected targets for the biochemical action of Al(III) and the reactivity of the metal centre towards both inorganic phosphates and nucleotides, diphosphoglycerate, phosphorylated proteins, phospholipids and myo-inositol-phosphates is thoroughly reviewed. All these data are evaluated in the light of the potential relevance of higher Al(III) levels to the etiopathology of dialysis dementia and of Alzheimer's disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.